Bristol-Myers Squibb Co stock sank Friday on speculation that its best-selling drug could face generic competition this year. Shares of Sanofi-Aventis SA, which markets blood thinner Plavix with Bristol-Myers, also fell on the news.
David Snow, CEO of pharmacy benefits manager Medco Health Solutions Inc, said on a conference call the company expects a generic version of blood thinner Plavix could launch later this year.
Medco spokeswoman Jennifer Luddy said the company had heard "market chatter that the generic could be available" and felt it was important to mention on the conference call because it could affect the company's earnings. Generic drugs are cheaper than their name brand counterparts and are more profitable for companies like Medco.
Luddy said she couldn't elaborate on the source of information and the company wasn't predicting there would definitely be a generic version of the drug.
Bristol-Myers shares fell US$1.36, or 5.7 percent, to US$22.43 on the New York Stock Exchange. Meanwhile, US shares of Sanofi-Aventis dipped US$1.68, or 3.6 percent, to US$45.24. Plavix is Paris-based Sanofi-Aventis' second best selling drug. Medco shares rose US$1.50, or 2.5 percent, to US$60.60.
The blood thinner's sales totaled US$5.9 billion last year. It is the second best-selling drug in the world after Pfizer Inc's cholesterol medicine Lipitor.
Canadian generic company Apotex Inc was challenging Plavix's patent and a trial was set to begin two months ago. However, Bristol-Myers and Sanofi-Aventis had reached an agreement to pay Apotex at least US$40 million so it wouldn't launch a generic version of Plavix until 2011.
Three experts in the high technology industry have said that US President Donald Trump’s pledge to impose higher tariffs on Taiwanese semiconductors is part of an effort to force Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to the negotiating table. In a speech to Republicans on Jan. 27, Trump said he intends to impose tariffs on Taiwan to bring chip production to the US. “The incentive is going to be they’re not going to want to pay a 25, 50 or even a 100 percent tax,” he said. Darson Chiu (邱達生), an economics professor at Taichung-based Tunghai University and director-general of
‘LEGACY CHIPS’: Chinese companies have dramatically increased mature chip production capacity, but the West’s drive for secure supply chains offers a lifeline for Taiwan When Powerchip Technology Corp (力晶科技) entered a deal with the eastern Chinese city of Hefei in 2015 to set up a new chip foundry, it hoped the move would help provide better access to the promising Chinese market. However, nine years later, that Chinese foundry, Nexchip Semiconductor Corp (合晶集成), has become one of its biggest rivals in the legacy chip space, leveraging steep discounts after Beijing’s localization call forced Powerchip to give up the once-lucrative business making integrated circuits for Chinese flat panels. Nexchip is among Chinese foundries quickly winning market share in the crucial US$56.3 billion industry of so-called legacy
Hon Hai Precision Industry Co (鴻海精密) is reportedly making another pass at Nissan Motor Co, as the Japanese automaker's tie-up with Honda Motor Co falls apart. Nissan shares rose as much as 6 percent after Taiwan’s Central News Agency reported that Hon Hai chairman Young Liu (劉揚偉) instructed former Nissan executive Jun Seki to connect with French carmaker Renault SA, which holds about 36 percent of Nissan’s stock. Hon Hai, the Taiwanese iPhone-maker also known as Foxconn Technology Group (富士康科技集團), was exploring an investment or buyout of Nissan last year, but backed off in December after the Japanese carmaker penned a deal
WASHINGTON POLICY: Tariffs of 10 percent or more and other new costs are tipped to hit shipments of small parcels, cutting export growth by 1.3 percentage points The decision by US President Donald Trump to ban Chinese companies from using a US tariff loophole would hit tens of billions of dollars of trade and reduce China’s economic growth this year, according to new estimates by economists at Nomura Holdings Inc. According to Nomura’s estimates, last year companies such as Shein (希音) and PDD Holdings Inc’s (拼多多控股) Temu shipped US$46 billion of small parcels to the US to take advantage of the rule that allows items with a declared value under US$800 to enter the US tariff-free. Tariffs of 10 percent or more and other new costs would slash such